Sodium sensitivity of blood pressure appears before hypertension in immunoglobulin A nephropathy, as glomerulosclerosis and interstitial damage progress. To find whether this sensitivity is related to NO and the renin-angiotensin system, we examined 39 such patients without hypertension after they followed a diet 
Introduction
Sodium-sensitive hypertension is an independent determinant of cardiovascular risk (1) , and sodium sensitivity of blood pressure in normotensive subjects is a risk factor for death (2) . The sodium sensitivity of blood pressure seems to be related to glomerular hypertension (3, 4) . Patients with parenchymal renal disease, including immunoglobulin A (IgA) nephropathy, come to have sodium-sensitive hyperteninhibits sodium uptake and reabsorption (10, 11) . In rats, NO inhibition causes sodium-sensitive hypertension (12) . In the Dahl salt-sensitive rat, a model of sodium-sensitive hypertension, renal NO synthesis is impaired (13) . In patients with chronic renal diseases, including IgA nephropathy, the urinary excretion of NOX (NO2 and NO3), used as a marker of NO production, is reduced (14, 15) .
In normotensive subjects with normal renal function, the renin-angiotensin-aldosterone system works to maintain systemic blood pressure during sodium restriction (16, 17) . However, in hypertensive patients, the renin system is blunted, and systemic blood pressure decreases when the sodium intake is low; the pressure increases when the sodium intake is high (18, 19) . So, the renin system helps to govern whether there is sodium sensitivity of blood pressure.
In patients with chronic glomerulonephritis (e.g., IgA nephropathy) but without hypertension, it is not clear whether the sodium sensitivity of blood pressure is related to NO synthesis, the renin-angiotensin-aldosterone system, both, or neither. For that reason, we studied patients with such nephropathy to examine the relationship between the sodium sensitivity index (SSI) and the two systems (the NO and renin-angiotensin-aldosterone systems) by measuring the urinary excretion of NOX, the plasma NOX level, plasma renin activity (PRA), and the serum aldosterone (ALD) level.
Methods Subjects
Eighty-nine patients with IgA nephropathy entered the study initially. All patients were hospitalized for the diagnosis and treatment of renal disease, both to be decided on the basis of results of a renal biopsy. We excluded patients with other renal diseases. After histological diagnosis, we informed patients about the purpose and methods of the study and obtained consent from 55 of the 89 patients. We wanted to clarify the causes of sodium sensitivity in patients with renal histological damage. Sodium sensitivity of blood pressure appears in patients with essential hypertension and without renal damage. For that reason, 16 patients whose blood pressure was ≥ 140 (systolic) or ≥ 90 (diastolic) mmHg in a period when they were given standard hospital meals with about 10 g of NaCl daily were excluded. Thirty-nine Japanese inpatients with IgA nephropathy participated in this study; the 11 men and 28 women were aged 20 to 59 years. Thirtythree of these patients were described earlier (8) . The patients' characteristics are shown in Table 1 . The study was approved by an institutional ethical committee. The patients were divided into two groups as described below.
Study Protocol
Before the study began, patients had standard hospital meals with about 10 g of NaCl daily. After at least 1 week at this level of sodium intake, the study was started. Patients were put on a low-sodium diet (about 5 g/day of NaCl) or one with an ordinary sodium level (about 12 g/day of NaCl) for 1 week at each level, in random order, with no time intervening. The two diets contained the same amounts of protein (1.2 g/kg of body weight daily) and the same number of calories (35 kcal/kg daily). Patients were asked to maintain their usual level of physical activity and to refrain from taking any medications (including steroids, nonsteroidal anti-inflammatory drugs, and antihypertensive drugs) for at least 1 week before and during the study. On each of the last 3 days of the two diets, 24-h urine collection was done and the urine was assayed for sodium, protein, urea nitrogen, and NOX. The means of each of these values for the 3 days are reported below. All urine was refrigerated, and portions were taken daily, frozen, and stored at 80 ºC until analysis. On the last day of each diet, a 24-h record of blood pressure was taken with an automatic monitor by oscillometry (Ambulatory Blood Monitoring System, A&D Co., Tokyo, Japan) with hourly measurements. One third of each pulse pressure was added to each diastolic pressure, and the mean of these values for each final day is given below as the mean arterial The renal blood flow was calculated from the effective renal flow and hematocrit. The MAP was divided by the renal blood flow for estimation of the renal vascular resistance. On the last day of each diet, blood samples were obtained at 8 AM, while patients were supine, for the measurement of electrolytes, plasma NOX, PRA, and ALD. Plasma and serum were separated from whole blood after centrifugation at 4 ºC, immediately frozen at 80 ºC, and kept frozen until analysis.
Plotting of Pressure-Natriuresis Relationship and SSI
Pressure-natriuresis curves were generated by the plotting of urinary sodium excretion on the ordinate as a function of MAP on the abscissa (5, 20) . When a linear relation between them is assumed, a curve for a patient can be drawn by linkage of the two datum points obtained when the patient's sodium balance is in a steady state during the two diets with different amounts of sodium. The SSI equals the reciprocal of the slope (5, 21) . The patients were divided into two groups at the median of this index, with the SSI of one group being 0.040 mmHg/mmol per day and that of the other group being ≥ 0.040 mmHg/mmol per day. In Table 1 , the characteristics of these groups are described; significant differences were not found.
Measurement of Urinary and Plasma NOX, PRA, and ALD
Urinary NOX levels were measured by the Griess method. In brief, 2 µl of the urine was diluted with 78 µl of assay buffer and to this, 10 µl of the cofactor and 10 µl of nitrite reductase were added (nitrate/nitrite colorimetric assay kit; Cayman Chemical Co., Ann Arbor, USA). After the urine was left at room temperature for 1 h to allow nitrate to be converted to nitrite, total nitrite was measured at the absorbance of 540 nm by reaction with Griess reagent. Amounts of nitrite in the urine were estimated by a standard curve obtained from enzymatic conversion of NaNO3 to nitrite. Plasma was deproteinized by the addition of an equal volume of methanol. After centrifugation at 5,000 g for 10 min, plasma NOX levels were measured with an NO analyzer (ENO-20; Eicom Co., Kyoto, Japan) (22) . PRA was measured by radioimmunoassay of angiotensin I, which is produced by renin. ALD was measured by radioimmunoassay.
Histological Study
Sections of biopsy specimens were stained with periodic acid-Schiff or periodic acid-Schiff-methenamine silver.
Biopsy specimens of all subjects had 10 glomeruli or more. All specimens were evaluated independently by two investigators unaware of the SSI of that patient. The severity of glomerulosclerosis and tubulointerstitial damage was evaluated semiquantitatively by a scoring method described in our previous study (23) .
Statistics
Values for patients' characteristics and hemodynamics are expressed as means SD. Urinary excretion of protein, SSI, the scores for histological damage, PRA, and differences in urinary excretion of NOX, plasma NOX, PRA, and ALD between the two diets are expressed as medians with the 25th to 75th percentiles because the values were not in a normal distribution. The significance of group differences between values during the two diets was evaluated by repeated-measures analysis of variance (ANOVA). The significance of group differences in age, body surface area, blood urea nitrogen, serum creatinine, and total protein was evaluated by Student's t-test for unpaired samples. The significance of group differences in the scores for histological damage and in changes in urinary excretion of NOX, plasma NOX, PRA, and ALD was evaluated by the Mann-Whitney U-test. The correlations of SSI with urinary excretion of NOX and changes in urinary excretion of NOX, plasma NOX, PRA, and ALD were evaluated by Spearman's correlation. Statistical analysis was done with Statistica, version 4.1J (StatSoft Inc., Tulsa, USA). Differences with p 0.05 were considered to be statistically significant.
Results
Results for urinary excretion of sodium, the hematocrit, systemic blood pressure, renal function, renal vascular resistance, and SSI in the two groups are in Table 2 . On the diet with a low sodium level, urinary excretion of sodium was not different in the two groups, nor was the hematocrit. However, on the diet with an ordinary sodium level, urinary excretion of sodium and the hematocrit were higher in the low-SSI group than in the high-SSI group; the hematocrit in the two groups was lower on the diet with an ordinary sodium level than on the diet with a low sodium level, and the decrease in the high-SSI group was greater than that in the low-SSI group. Systemic blood pressure on the diet with an ordinary sodium level was higher in the high-SSI group than in the low-SSI group, but the systemic pressure on the diet with a low sodium level was not different in the two groups. Creatinine clearance on each diet was lower in the high-SSI group than in the low-SSI group. The clearance in each group was higher on the diet with an ordinary sodium level than on the diet with a low sodium level. Effective renal plasma flow was not different in the two groups. However, in the low-SSI group, the renal plasma flow was higher on the diet with an ordinary sodium level than on the diet with a low sodium level; in the high-SSI group, the flow was not different between the diets. The renal vascular resistance on the diet with a low sodium level was not different in the two groups, but the resistance on the diet with an ordinary sodium level was lower in the low-SSI group than in the high-SSI group. The renal vascular resistance in each group was not different in the two diets.
Results for urinary excretion of protein and urea nitrogen are in Table 3 , as are scores for renal histological damage in the two groups. In the high-SSI group, urinary excretion of protein was higher on the diet with an ordinary sodium level than that with a low sodium level, but in the low-SSI group, the excretion of protein was not different in the two diets. The urinary excretion of protein on each diet was higher in the high-SSI group than in the low-SSI group. Significant differences were not found in the urinary excretion of urea nitrogen. The glomerulosclerosis score and the score for tubulointerstitial damage were higher in the high-SSI group than in the low-SSI group.
Urinary excretion of NOX in the low-SSI group was higher on the diet with an ordinary sodium level than that with a low sodium level (Fig. 1a) . Urinary excretion of NOX in the high-SSI group was not different during the different diets. Urinary excretion of NOX on the diet with an ordinary sodium level was higher in the low-SSI group than in the high-SSI group, but urinary excretion of NOX with a low sodium level was not different in the groups. Significant differences were not found in the plasma concentration of NOX (Fig. 1b) . Urinary excretion of NOX during the diet with an ordinary sodium level was significantly correlated with the SSI (ρ 0.406, p 0.013, n 39). Correlation of urinary excretion of NOX on the diet with a low sodium level with the SSI was not significant (ρ 0.255, p 0.12, n 39). The changes in urinary excretion of NOX were not significantly different in the two groups (low-SSI group, 251 [ 16, 414] µmol/day, and high-SSI group, 25 [ 213, 297] µmol/day, p 0.14). The changes in plasma NOX were not different (low-SSI group, 0.8 [ 3.6, 22.3] µmol/l, and high-SSI . Changes in plasma NOX also were not significantly correlated with the SSI (ρ 0.334, p 0.068, n 39). PRA and ALD in each group were significantly higher on the diet with a low sodium level than on the diet with an ordinary sodium level (Table 4) . PRA and ALD on each diet were significantly higher in the low-SSI group than in the high-SSI group. The difference in PRA depending on whether sodium intake was low or ordinary was 2.1 (0.7, 2.9) ng/ml per hour in the low-SSI group, greater than this difference in the high-SSI group, 0.5 (0.2, 1.0) ng/ml per hour. Changes in ALD were higher in the low-SSI group (11.8 [4.9, 18 .6] ng/dl) than in the high-SSI group (4.0 [1.8, 7.3] ng/dl). Changes in PRA were significantly correlated with SSI (Fig. 2a) , as were changes in ALD (Fig. 2b) .
Discussion
In our 20 patients with IgA nephropathy and moderate renal histological damage, the mean responses of both renal NO synthesis and the renin-angiotensin-aldosterone system to changes in sodium intake were blunted. The lack of response seems to be related to sodium sensitivity of blood pressure even before hypertension appears.
An experimental study has shown that the endogenous NO system participates in the physiological renal adaptation to increased dietary sodium intake (9) . In studies done with microperfusion, NO synthesis in normal kidneys is increased by an increase in sodium intake, and the increased NO blunts the tubuloglomerular feedback, thereby increasing the urinary excretion of sodium (10, 11) . Urinary excretion and the plasma concentration of NOX reflect total NO production or activity in vivo (9) . In particular, urinary excretion of NOX is related to renal production of NO and urinary sodium excretion (9) . In humans, total NO production or activity is assessed by urinary excretion and plasma concentrations of NOX. Urinary excretion of NOX in patients with chronic renal failure is reduced (14) . In IgA nephropathy, the urinary excretion of NOX is reduced in those patients who are hypertensive (15) . In our patients, all with IgA nephropathy but with- PRA is given as the medians followed in parentheses by the 25th and 75th percentiles, and ALD is given as the means SD. SSI, sodium sensitivity index. p 0.05 and p 0.01 between diets. Repeated-measures ANOVA.
out hypertension or renal failure, the change in urinary excretion of NOX in response to an increase in sodium intake was different in the low-and high-SSI groups: such excretion increased in low-SSI patients but not in high-SSI patients, most of whom had higher scores for glomerulosclerosis and tubulointerstitial damage. In such high-SSI patients, the sodium sensitivity of blood pressure seems to be related to impairment in the NO synthesis response to sodium intake. Dahl salt-sensitive rats have genetically based sodiumsensitive hypertension. In these rats, NO generation is impaired, and the renal expression of endothelial and neuronal NO synthase is decreased (24) . The decreased expression of NO synthase and tubulointerstitial injury of the rats parallel the development of hypertension (24) . The results of our study are compatible with these findings from an animal study. Urinary excretion of NOX on the diet with an ordinary sodium level was higher in the low-SSI group than in the high-SSI group. However, in these groups, the changes in urinary excretion of NOX caused by the increase in sodium intake were not significantly different. Urinary excretion of NOX may reflect renal NO production, but systemic NO production and NOX intake modify this excretion. In this study, the patients refrained from taking any medication and had the same intake of protein throughout. In addition, values of urinary excretion were the means of the values for 3 days. These aspects of the protocol were intended to exclude the effects of systemic NO production and NOX intake, but might not have been sufficient, possibly accounting for the lack of a significant difference in the excretion of NOX. Urinary excretion of sodium was different between the two groups on the diet with an ordinary sodium level. On that diet, however, actual sodium intake was unlikely to be different between the groups, because the urinary excretion of urea nitrogen was not different. The hematocrit on the diet with an ordinary sodium level was lower in the high-SSI group than in the low-SSI group. This phenomenon shows sodium retention (decreased urinary excretion of sodium) in the high-SSI group.
Reactive increases in PRA and ALD during sodium restriction are important for the maintenance of blood pressure in normotensive subjects (16, 17) . However, in hypertensive patients, especially sodium-sensitive ones, the reactive increases in PRA and ALD are attenuated and the blood pressure is lowered when sodium intake is restricted (18, 19) . In our patients with IgA nephropathy and a high SSI, during sodium restriction, the increases in PRA and ALD were attenuated and the blood pressure was lowered to levels similar to those of the patients with low SSI. The renin-angiotensin-aldosterone system working for sodium retention may affect the sodium sensitivity of blood pressure. In other words, the system seems to be attenuated in patients with IgA nephropathy and high SSI.
Sodium sensitivity of blood pressure is increased by a decrease in the whole-kidney ultrafiltration coefficient, an increase in tubular sodium reabsorption, or both (25) . Our recent study of patients with IgA nephropathy showed that the sodium sensitivity of blood pressure is significantly correlated with glomerulosclerosis (8) . The more the number of glomeruli is decreased, the more blood pressure becomes sodium-sensitive. However, it is not clear whether tubular reabsorption of sodium is increased in sodium-sensitive patients with IgA nephropathy. In normal kidneys, when sodium intake is increased, renal NO generation increases and inhibits the tubular reabsorption of sodium (9) . We here showed that increases in NO synthesis in response to an increase in sodium intake are impaired in sodium-sensitive patients with IgA nephropathy. Therefore, in such patients, the capacity for sodium excretion via the NO system may be decreased. In our patients with low sodium sensitivity, small decreases in systemic pressure were found when the sodium intake was restricted to about 5 g of NaCl daily. In our patients with high sodium sensitivity, a large decrease in systemic blood pressure was seen. In sodium-sensitive patients with IgA nephropathy, the systemic blood pressure seemed to be decreased, probably because renal vascular resistance cannot increase owing to bluntness of the response of the renin-angiotensin system when sodium intake decreases. Sodium restriction may decrease the risk of a cardiovascular event and renal death in such sodium-sensitive subjects.
In conclusion, we showed that in one kind of chronic glomerulonephritis, IgA nephropathy, bluntness of the responses of the NO system and the renin-angiotensin-aldosterone system appears in patients with moderate renal histological damage but without hypertension, and is related to the sodium sensitivity of blood pressure. In such patients, sodium restriction seems to be important for treatment of IgA nephropathy to decrease the risk of cardiovascular events or renal death.
